La Rosa to Implement 80-for-1 Reverse Stock Split; Shares Down Pre-Bell-February 2024-www.financetom.com

La Rosa to Implement 80-for-1 Reverse Stock Split; Shares Down Pre-Bell

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

La Rosa to Implement 80-for-1 Reverse Stock Split; Shares Down Pre-Bell

Jul 2, 2025 6:41 AM

09:24 AM EDT, 07/02/2025 (MT Newswires) -- La Rosa Holdings ( LRHC ) said Wednesday it will implement an 80-for-1 reverse stock split to help regain compliance with Nasdaq's minimum bid price rule.

The company said its stock will start trading on a split-adjusted basis when the market opens Monday.

Shares of La Rosa were down 31% in recent premarket activity.

Previous page： UBS Reorganizing Global Wealth Management Arm Next page： SM Energy buys XCL Resources' shale assets for $2 bln

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

UBS Reorganizing Global Wealth Management Arm

Jun 27, 2024

07:23 AM EDT, 06/27/2024 (MT Newswires) -- UBS (UBS) is reorganizing its global wealth management arm as part of its strategy to offer more investment services to its ultra-rich client base, multiple news outlets reported Thursday. A new unit, GWM Solutions, has been created to consolidate the company's wealth offerings, with former Credit Suisse wealth banker Yves-Alain Sommerhalder as head,...

SM Energy buys XCL Resources' shale assets for $2 bln

Jun 27, 2024

June 27 (Reuters) - SM Energy ( SM ) said on Thursday it had agreed to buy some assets of shale-focused producer XCL Resources for about $2 billion from private-equity firm EnCap Investments, extending its footprint in the Uinta region in Utah. Northern Oil and Gas ( NOG ) will also buy 20% of the oil and gas assets of...

Elanco Animal Health Updates US FDA Approval Timelines for Two Drugs; Boosts 2024 Innovation Sales Outlook

Jun 27, 2024

07:26 AM EDT, 06/27/2024 (MT Newswires) -- Elanco Animal Health ( ELAN ) said Thursday that it has made progress in gaining US Food and Drug Administration approval for its drugs Zenrelia and Credelio Quattro. For Zenrelia, the company said it expects approval in Q3 followed by a US launch in Q4. For Credelio Quattro, the company said it expects...

Levi Strauss Pegs 2024 Revenue at Guidance Midpoint as Second-Quarter Result Misses Street

Jun 27, 2024

07:23 AM EDT, 06/27/2024 (MT Newswires) -- Levi Strauss (LEVI) kept its outlook for full-year revenue growth, but said the result is now expected in the middle of the range after the outcome in the second quarter missed estimates, despite growing 8% year over year. The jeans and clothes company expects reported revenue growth to be at the midpoint of...